NCT07113782View on ClinicalTrials.gov

Comparison of Magnesium Sulphate vs Tramadol as Adjuvants in Intrathecal Bupivacaine for Postoperative Pain in TURP Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Benign Prostatic Hyperplasia Postoperative Pain
Interventions
DRUG

1. Magnesium Sulphate 2. Tramadol

"Magnesium Sulphate (Group M): 50 mg magnesium sulphate added to 12.5 mg of 0.5% hyperbaric bupivacaine, administered intrathecally.~Tramadol (Group T): 25 mg tramadol added to 12.5 mg of 0.5% hyperbaric bupivacaine, administered intrathecally."

Trial Locations (1)

52250

AFIU, Rawalpindi

All Listed Sponsors
lead

Armed Forces Institute of Urology, Rawalpindi

OTHER

NCT07113782 - Comparison of Magnesium Sulphate vs Tramadol as Adjuvants in Intrathecal Bupivacaine for Postoperative Pain in TURP Patients | Biotech Hunter | Biotech Hunter